More News
16 February 2022
Aquinnah Pharmaceuticals Announces Collaboration with Roche to Advance New Therapies for ALS and Other Neurodegenerative Diseases4 February 2022
Mersana Therapeutics Announces Research Collaboration and License Agreement with Janssen to Advance Novel Antibody-Drug Conjugates3 February 2022
Amgen and Plexium announce multi-year, drug discovery collaboration to identify novel targeted protein degradation therapies1 February 2022
Ethris Raises $26.3 Million Series B to Advance Pipeline of mRNA-based Therapeutics for Respiratory Diseases28 January 2022
Biogen Reaches Agreement with Samsung Biologics to Sell Equity Stake in Their Biosimilar Joint Venture for up to $2.3 billion19 January 2022
Altos Labs launches with the goal to transform medicine through cellular rejuvenation programming19 January 2022
Ceptur Therapeutics Launches with $75M Series A Financing to Advance RNA Therapeutics Based on Proprietary U1 Adaptor Technology19 January 2022
UCB to acquire Zogenix18 January 2022
23andMe Announces Extension of GSK Collaboration and Update on Joint Immuno-oncology Program18 January 2022
Amagma Therapeutics Announces Strategic Partnership with Innovent Biologics in Inflammatory Diseases18 January 2022
Transgene and PersonGen Announce Collaboration to Evaluate a New Combination Therapy Against Solid Tumors18 January 2022
Almirall and IRB Barcelona announce a research collaboration to discover novel molecular glue therapeutics for severe skin diseases17 January 2022
ReviR Therapeutics Raises ~$20M in Pre-A Financing12 January 2022
Fusion Pharmaceuticals Announces Research Collaboration with Pepscan to Develop Peptide-Based Radiopharmaceuticals12 January 2022
Fusion Pharmaceuticals Announces Research Collaboration with 48Hour Discovery to Develop Peptide-Based Radiopharmaceuticals12 January 2022
NeoCura and PhoreMost Announce Research Collaboration to Explore Novel Cancer Therapeutics12 January 2022
ABL Bio Enters Global Collaboration and License Agreement with SANOFI to Advance ABL301 for the Treatment of Parkinson’s DiseaseNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports